← Back to Search

Behavioural Intervention

High-Intensity Interval Training for Pediatric Heart Transplant Recipients

N/A
Recruiting
Led By Michael Khoury, MD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 13 months
Awards & highlights

Study Summary

This trial is testing a new way to do high-intensity interval training at home using a video game and a bike. They want to see if it's feasible and if it leads to better outcomes for pediatric heart transplant recipients.

Who is the study for?
This trial is for pediatric heart transplant recipients aged 10-18 years, who are at least 6 months post-transplant. It's not for those with multiple organ transplants, non-English speakers, or if their home can't fit the MedBIKE™ system. Kids with exercise restrictions from doctors, recent rejections, serious heart dysfunction, chest pain during exertion, certain arrhythmias or illnesses that limit exercise aren't eligible.Check my eligibility
What is being tested?
The study tests a home-based high-intensity interval training (HIIT) program using MedBIKE™—a video game-linked bike—for improving fitness in kids who've had a heart transplant. The goal is to see if this intense but short burst workout method can boost their cardiorespiratory health more than traditional moderate exercises.See study design
What are the potential side effects?
While specific side effects of HIIT on pediatric heart transplant patients are not detailed here and may vary individually, common reactions to intense exercise could include muscle soreness, fatigue and in rare cases exacerbation of underlying cardiac conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~13 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 13 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluate the feasibility of a 12-week, home-based HIIT MedBIKE™ intervention in pediatric heart transplant recipients.
Secondary outcome measures
Changes in cardiac specific health-related quality of life will be measured using the PedsQL Cardiac Module questionnaire.
Changes in physical activity, defined as time spent in moderate to vigorous physical activity (MVPA) and sedentary time, measured by wearing an accelerometer for 7-days prior and 7-days post MedBIKE intervention
Changes in self efficacy towards physical activity measured on the Children's Self-Perceptions of Adequacy in and Predilection for Physical Activity (CSAPPA) scale.
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MedBIKE HIITExperimental Treatment1 Intervention
Participants will complete the baseline assessments and begin the MedBIKE HIIT Exercise Program intervention within 2-weeks. After the completion of the 12-week program, participants will return for follow-up assessments which will be repeated at 6- and 12-months post intervention.
Group II: Standard of CareActive Control1 Intervention
Participants will complete the baseline assessments and continue with standard of care (no intervention) for 12-weeks then return for a repeat assessment. Participants will then crossover into the MedBIKE HIIT Exercise Program intervention group for 12-weeks. A post-intervention assessment will be completed and follow-up assessments at 6- and 12-months post intervention.

Find a Location

Who is running the clinical trial?

Women and Children's Health Research Institute, CanadaOTHER
17 Previous Clinical Trials
24,930 Total Patients Enrolled
Canadian Donation and Transplantation Research ProgramUNKNOWN
1 Previous Clinical Trials
25 Total Patients Enrolled
University of AlbertaLead Sponsor
888 Previous Clinical Trials
384,948 Total Patients Enrolled

Media Library

MedBIKE HIIT (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05451979 — N/A
Acute Lymphoblastic Leukemia Research Study Groups: MedBIKE HIIT, Standard of Care
Acute Lymphoblastic Leukemia Clinical Trial 2023: MedBIKE HIIT Highlights & Side Effects. Trial Name: NCT05451979 — N/A
MedBIKE HIIT (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05451979 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly individuals being considered as trial participants?

"This research project is recruiting participants who are between the ages of 10 and 18."

Answered by AI

Are there any vacancies remaining in this experiment?

"Clinicaltrials.gov informs us that this clinical trial is currently enrolling patients, having been initially listed on February 22nd 2022 and last edited on July 6th 2022."

Answered by AI

Am I eligible to join this research endeavor?

"The investigators of this medical trial seek 10 minors, aged between 10 and 18 years old, who have previously undergone a pediatric heart transplantation. Moreover, the participants must be at least 6 months out from their surgery."

Answered by AI

How many participants has this research endeavor recruited thus far?

"Affirmative. Per the information presented on clinicaltrials.gov, this medical trial is actively recruiting patients as of July 6th 2022. This study was originally posted to the website on February 22nd and 10 individuals are required from 1 location."

Answered by AI
~2 spots leftby Dec 2024